FDA Panel Recommends Approval Of Pfizer COVID-19 Vaccine For Emergency Use
The Food and Drug Administration’s advisory panel voted on Thursday to recommend Pfizer’s COVID vaccine should be used on an emergency basis. The vaccine has yet to be authorized by the FDA, but the panel’s approval for emergency use is a promising sign. If approved, the first recipients would be health care workers and nursing home residents, which could start as early as next week. The advisory panel spent time reviewing data from Pfizer’s vaccine trials and shared their opinions and thoughts with the FDA. While the FDA is not required to follow the panel’s advice, their recommendations are ...